1. Home
  2. MCR vs PGEN Comparison

MCR vs PGEN Comparison

Compare MCR & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCR
  • PGEN
  • Stock Information
  • Founded
  • MCR 1989
  • PGEN 1998
  • Country
  • MCR United States
  • PGEN United States
  • Employees
  • MCR N/A
  • PGEN N/A
  • Industry
  • MCR Trusts Except Educational Religious and Charitable
  • PGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCR Finance
  • PGEN Health Care
  • Exchange
  • MCR Nasdaq
  • PGEN Nasdaq
  • Market Cap
  • MCR 263.0M
  • PGEN 292.6M
  • IPO Year
  • MCR N/A
  • PGEN N/A
  • Fundamental
  • Price
  • MCR $6.17
  • PGEN $0.82
  • Analyst Decision
  • MCR
  • PGEN Buy
  • Analyst Count
  • MCR 0
  • PGEN 5
  • Target Price
  • MCR N/A
  • PGEN $7.00
  • AVG Volume (30 Days)
  • MCR 66.7K
  • PGEN 792.5K
  • Earning Date
  • MCR 01-01-0001
  • PGEN 11-26-2024
  • Dividend Yield
  • MCR 8.52%
  • PGEN N/A
  • EPS Growth
  • MCR N/A
  • PGEN N/A
  • EPS
  • MCR 0.38
  • PGEN N/A
  • Revenue
  • MCR N/A
  • PGEN $3,963,000.00
  • Revenue This Year
  • MCR N/A
  • PGEN N/A
  • Revenue Next Year
  • MCR N/A
  • PGEN $211.35
  • P/E Ratio
  • MCR $16.61
  • PGEN N/A
  • Revenue Growth
  • MCR N/A
  • PGEN N/A
  • 52 Week Low
  • MCR $5.63
  • PGEN $0.78
  • 52 Week High
  • MCR $6.70
  • PGEN $1.93
  • Technical
  • Relative Strength Index (RSI)
  • MCR 27.76
  • PGEN 40.32
  • Support Level
  • MCR $6.30
  • PGEN $0.89
  • Resistance Level
  • MCR $6.42
  • PGEN $1.05
  • Average True Range (ATR)
  • MCR 0.05
  • PGEN 0.06
  • MACD
  • MCR -0.02
  • PGEN 0.00
  • Stochastic Oscillator
  • MCR 1.92
  • PGEN 14.50

About MCR MFS Charter Income Trust

MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: